Related Experiment Video
Updated: Aug 9, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[Etiology of Crohn disease. Current data]
Abstract:
Both genetic and environmental factors appear to play an aetiologic role in Crohn's disease. The hypothesis of genetic susceptibility is based on the frequency of familial forms (6-33%) and higher relative risk in first degree relatives (x10 to x21). Three genetic segregation analyses have defined a genetic model favouring autosomal recessive transmission and incomplete penetration. The frequency of the deleterious allele would be 0.01 in the general population. One-third of all patients would be homozygous. To date, no genetic marker has been found for Crohn's disease although in one study, molecular biology techniques revealed a significant association between the HLA-DR1, DQW5 genotypes, and the association DR1/DQW5, and Crohn's disease. There are also many arguments in favour of an environmental cause, including: increased incidence since the Second World War, a north-south incidence gradient (established in the US and probable in Europe), predominance in urban areas. In addition, 21 conjugal forms were recently reported in the US, including 14 which appeared after marriage. We have also observed 10 conjugal forms in a limited area in northern France and in Belgium. Smoking has also been shown to have a detrimental effect, perhaps via modifications in the microcirculation of the intestinal wall. Despite contradictory results, oestrogen-progesterone treatment does not appear to increase the risk of Crohn's disease and there is no convincing evidence that any particular food could be incriminated. In contradiction with a widely believed myth, there is no evidence showing that psychiatric factors have an effect on appearance or aggravation of the disease. Perinatal infection has however been recently shown to affect incidence and subjects born during periods of flu epidemics have a higher relative risk. Still other studies have emphasized the dual role of genetic/environmental factors. Based on current knowledge, the sequence leading to the appearance of Crohn's disease would include one or more perinatal event(s) such as viral infection acting on a genetically susceptible subject and leading to modified immune response in a vulnerable system (perinatal period). Later in life an aggression (environment) would lead to inappropriate immune response. Current research is directed towards identifying infectious agents capable of triggering the disease and on markers of genetic susceptibility.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

